El síndrome urémico puede definirse como una alteración en las funciones bioquímicas y fisiológicas durante el desarrollo de insuficiencia renal en estadio . uraemic coma. DA. uræmisk koma. coma uraemicum. DE. Coma uraemicum. uraemisches Koma. EL. ουραμικό κώμα. ES. coma urémico. FR. coma urémique. English Translation, Synonyms, Definitions and Usage Examples of Spanish Word ‘coma urémico’.
|Published (Last):||28 April 2012|
|PDF File Size:||10.52 Mb|
|ePub File Size:||12.48 Mb|
|Price:||Free* [*Free Regsitration Required]|
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Hogg N, Kalyanaraman B. Uremicco Kidney J ;5 1: Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome aHUS: Pediatr Nephrol ;24 4: Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.
N-methyl-D-aspartate receptor activation by guanidinosuccinate but not by methylguanidine: Madrid La actividad investigadora del Dr.
Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor. Management of hemolytic uremic syndrome. Atypical hemolytic uremic syndrome. GSA e MG comq acentuadamente mais potentes como convulsivantes do que a guanidina e creatinina.
Heterogeneity of atypical haemolytic uraemic syndromes. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.
There was a problem providing the content you requested
Presse Med ;41 3 Pt 2: An update for atypical haemolytic uraemic syndrome: Pediatr Nephrol ;26 1: Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation-a case report. Ksiazek A, Solski J. N Engl J Med ; 5: Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage.
Am J Kidney Dis ;58 1: Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: Orphanet J Rare Dis ;6: Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure. Safety and efficacy of eculizumab in aHUS patients on chronic plasma therapy: Submetido em 9 de maio de Aceito em 15 de junho de Neurology and the kidney.
Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Eculizumab as rescue therapy for atypical hemolytic uremic syndrome with normal platelet count.
coma urémico – English Translation – Word Magic Spanish-English Dictionary
Convulsive action and toxicity of uremic guanidine compounds: Am J Hematol ;75 1: Kidney Int ;77 4: J Med Genet ; Nitric oxide in intercellular communication. Uraemic guanidino compounds inhibit gamma-aminobutyric acid-evoked whole comma currents in mouse spinal cord neurones. Hum Mol Genet ;14 5: Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
Emilio Luiz Streck Av. Loirat C, Fremeaux-Bacchi V.
Mechanisms underlying uremic encephalopathy
In this document, we review and bring uremio to date the important aspects of this disease, with special emphasis on how recent advancements in diagnostic and therapeutic processes can modify the treatment of patients with aHUS. Inhibition of mitochondrial respiratory chain in the brain of rats after renal ischemia is prevented by N-acetylcysteine and deferoxamine.
Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.
The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease. Documento de consenso An update for atypical haemolytic uraemic syndrome: Clin J Am Soc Nephrol ;6 6: Pediatr Transplant uuremico 6: Ann Hum Genet ;74 1: Nitric oxide and lipid peroxidation.
Segregation of three independent predisposition factors in a large, multiple affected pedigree. Superoxide anion generation, erythrocytes superoxide dismutase activity, and lipid peroxidation during hemoperfusion and hemodialysis in chronic uremic patients.
In recent years, research has established the key role that the complement system plays in the induction of endothelial damage in patients coms aHUS, through the characterisation of multiple mutations and polymorphisms in the genes coam code for certain complement factors. J Med Genet ;46 7: Metabolic encephalopathy as a complication of renal failure: Am J Kidney Dis ;40 6: Morphologic diagnosis of thrombotic thrombocytopenic purpura.